Please login to the form below

Not currently logged in
Email:
Password:

HCA Benchmarking Survey

This page shows the latest HCA Benchmarking Survey news and features for those working in and with pharma, biotech and healthcare.

Flexible working tops benefits comms agencies offer

HCA survey looks at employee perks at healthcare agencies. Most UK healthcare communications agencies offer new staff a range of benefits, with flexible working almost ubiquitous, according to a new survey. ... HCA (Healthcare Communications Association)

Latest news

  • HCA benchmarking survey

    Association (HCA) Benchmarking Survey. ... ìThe survey has confirmed a need to grow the talent pool of healthcare PR consultants, î said Fiona Hall, chair of the Agency Benchmarking Survey.

  • Spending wisely

    The HCA benchmarking survey highlighted that demonstration of RoI is the single biggest factor likely to lead to further increases in the use of PR. ... The HCA benchmarking survey indicated that in 77 per cent of participating pharma companies, the use

More from news
Approximately 1 fully matching, plus 2 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Swordfish Advertising

At Swordfish Advertising, we believe building an effective brand shouldn't be stressful. Don't get us wrong; it takes blood, sweat...

Latest intelligence

Report: Achieving launch excellence in the challenging healthcare markets of today
Our in-depth report is based on original data and expert interviews, which coupled with our own experience, ensures we give you the best recommendations for achieving launch success in challenging...
What is blockchain and why should i care - Richard Springham
Four Health - Emerging Technologies The power of blockchain lies in the fact it can prove that a unique event occurred at a certain time with out the need to...
NHS medicines optimisation milestone
Steve How, Paul Midgley and Oli Hudson, of the Wilmington Healthcare Consulting Team, explore the implications of Adalimumab’s recent European patent expiry...

Infographics